Enzymatica: Comments on Plos One’s study investigation - Redeye

Redeye has noted Dagens Medicin’s article and Plos One’s investigation regarding a ColdZyme study from 2019. Dagens Medicin has questioned the study's conclusion and argues the overall negative study results are not reflected in the conclusion section. We are looking into the situation and will return once the investigation ends.

Länk till analysen i sin helhet: https://www.redeye.se/research/890869/enzymatica-comments-on-plos-ones-study-investigation?utm_source=finwire&utm_medium=RSS